- Home
- SNSE vs USEA Comparison
SNSE vs USEA Comparison
Compare SNSE & USEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNSE
- USEA
- Stock Information
- Founded
- SNSE 2005
- USEA 2004
- Country
- SNSE United States
- USEA Greece
- Employees
- SNSE N/A
- USEA N/A
- Industry
- SNSE Biotechnology: Pharmaceutical Preparations
- USEA Marine Transportation
- Sector
- SNSE Health Care
- USEA Consumer Discretionary
- Exchange
- SNSE Nasdaq
- USEA Nasdaq
- Market Cap
- SNSE 10.8M
- USEA 10.5M
- IPO Year
- SNSE 2021
- USEA N/A
- Fundamental
- Price
- SNSE $7.76
- USEA $1.57
- Analyst Decision
- SNSE Strong Buy
- USEA
- Analyst Count
- SNSE 4
- USEA 0
- Target Price
- SNSE $72.50
- USEA N/A
- AVG Volume (30 Days)
- SNSE 25.9K
- USEA 23.2K
- Earning Date
- SNSE 08-05-2025
- USEA 08-06-2025
- Dividend Yield
- SNSE N/A
- USEA 2.55%
- EPS Growth
- SNSE N/A
- USEA N/A
- EPS
- SNSE N/A
- USEA N/A
- Revenue
- SNSE N/A
- USEA $42,595,000.00
- Revenue This Year
- SNSE N/A
- USEA N/A
- Revenue Next Year
- SNSE N/A
- USEA $11.62
- P/E Ratio
- SNSE N/A
- USEA N/A
- Revenue Growth
- SNSE N/A
- USEA N/A
- 52 Week Low
- SNSE $5.00
- USEA $1.00
- 52 Week High
- SNSE $17.40
- USEA $2.78
- Technical
- Relative Strength Index (RSI)
- SNSE 52.43
- USEA 58.51
- Support Level
- SNSE $6.33
- USEA $1.53
- Resistance Level
- SNSE $10.99
- USEA $1.61
- Average True Range (ATR)
- SNSE 1.00
- USEA 0.06
- MACD
- SNSE 0.12
- USEA -0.01
- Stochastic Oscillator
- SNSE 41.04
- USEA 91.95
About SNSE Sensei Biotherapeutics Inc.
Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101 (VISTA), SNS-102 (VSIG4 ), SNS-103 (ENTPDase/CD39), SNS-201 (VISTAxCD28).
About USEA United Maritime Corporation
United Maritime Corp operates as a shipping company currently specializing in the seaborne transportation of dry bulk commodities. It currently operates one LR2 tanker vessel and three Capesize dry bulk vessels, two Kamsarmax dry bulk vessels, and three Panamax dry bulk vessels, with an aggregate cargo-carrying capacity of approximately 1,004,289 dwt.